Bulletin

WHO

CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer

April 22, 2022

Roche

CHMP recommends EU conditional approval of Roche’s potential first-in-class bispecific antibody mosunetuzumab for people with relapsed or refractory follicular lymphoma

April 22, 2022

WHO

Virtual Press Conference on COVID-19 and other global health issues

April 13, 2022

WHO

Statement on the eleventh meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic

April 13, 2022

WHO

WHO delivers 20 ambulances to Ukraine

April 8, 2022

WHO

WHO records 100th attack on health care in Ukraine

April 7, 2022

WHO

WHO Director-General, World Health Day Joint Press Conference with US HHS Secretary Becerra, Washington

April 7, 2022

WHO

WHO public hearings regarding a new international instrument on pandemic preparedness and response: “The World Together”

April 7, 2022

WHO

WHO urges accelerated action to protect human health and combat the climate crisis at a time of heightened conflict and fragility

April 6, 2022

Roche

Ad hoc announcement pursuant to Art. 53 LR Roche provides update on phase III SKYSCRAPER-02 study in extensive-stage small cell lung cancer

March 30, 2022

WHO

Egypt and Nigeria medicines regulators achieve high maturity level in WHO classification and WHO launches list of regulatory authorities that meet international standards

March 30, 2022

< 1 … 61 62 63 64 65 66 67 68 69 … 94 >

Bulletin

Virtual Press Conference on COVID-19 and other global health issues

India’s Pharma exports grow by 103% since 2013-14

Ebola virus disease - Democratic Republic of the Congo

WHO reveals shocking extent of exploitative formula milk marketing

2022 ISPE Facility of the Year Category Award Winners Announced

CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer

CHMP recommends EU conditional approval of Roche’s potential first-in-class bispecific antibody mosunetuzumab for people with relapsed or refractory follicular lymphoma

Virtual Press Conference on COVID-19 and other global health issues

Statement on the eleventh meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic

WHO delivers 20 ambulances to Ukraine

WHO records 100th attack on health care in Ukraine

WHO Director-General, World Health Day Joint Press Conference with US HHS Secretary Becerra, Washington

WHO public hearings regarding a new international instrument on pandemic preparedness and response: “The World Together”

WHO urges accelerated action to protect human health and combat the climate crisis at a time of heightened conflict and fragility

Ad hoc announcement pursuant to Art. 53 LR Roche provides update on phase III SKYSCRAPER-02 study in extensive-stage small cell lung cancer

Egypt and Nigeria medicines regulators achieve high maturity level in WHO classification and WHO launches list of regulatory authorities that meet international standards

Company

Resources